FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (ScieGen Pharmaceuticals Inc)

View source ↗

Summary

The FDA approved a supplemental application for ScieGen Pharmaceuticals Inc to market a generic pramipexole dihydrochloride product for the treatment of Parkins…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Restless Legs Syndrome

Drugs mentioned

• Pramipexole dihydrochloride (pramipexole dihydrochloride)

Snippet

SUPPL AP for PRAMIPEXOLE DIHYDROCHLORIDE (PRAMIPEXOLE DIHYDROCHLORIDE)